CSF3 and plasma cell myeloma: The study by Rodríguez-Lobato et al. (33) found that, for patients with multiple myeloma in at-home ASCT, the avoidance of G-CSF and the addition of primary prophylaxis with corticosteroids after ASCT minimizes the incidence rates of neutropenic fever and engraftment syndrome.